• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Genelux Corporation - Common Stock (NQ:GNLX)

2.420 -0.060 (-2.42%)
Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 277,874
Open 2.480
Bid (Size) 2.360 (2,000)
Ask (Size) 2.690 (100)
Prev. Close 2.480
Today's Range 2.355 - 2.520
52wk Range 2.290 - 8.535
Shares Outstanding 38,051,771
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stay updated with the stocks that are on the move in today's after-hours session. ↗
September 09, 2026
Via Chartmill
News headline image
Genelux Announces Publication of a Deep and Durable Response in a Platinum-relapsed Small Cell Lung Cancer Patient Following Systemically Delivered Olvi-Vec-Primed Immunochemotherapy
September 09, 2026
From Genelux Corporation
Via GlobeNewswire

Performance

52-Week Range 71.6% below 52-week high
2.420
2.2952W Low 8.5452W High
1 Week 6.6% below 1-week high
2.321W Low 2.591W High

Genelux Corporation - Common Stock (GNLX) traded between $2.29 and $8.54 over the past 52 weeks and last traded at $2.42, 71.6% below its 52-week high. Over the past week it ranged between $2.32 and $2.59.

Past 12 Months
-4.9%
-4.3%
-17.4%
-8.7%
-46.8%
-57.7%
1W -$0.12
1M -$0.11
3M -$0.51
6M -$0.23
YTD -$2.13
1Y -$3.30

GNLX was -57.7% over the past year, -8.7% over six months, -46.8% year to date, -4.9% in the last week.

12 Months vs Market
GNLX
-57.7%
DIA
+12.4%
SPY
+14.9%
QQQ
+17.5%
IWM
+11.1%

Over the past 12 months GNLX returned -57.7% versus DIA (Dow) +12.4%, SPY (S&P 500) +14.9%, QQQ (Nasdaq 100) +17.5% and IWM (Russell 2000) +11.1%.

Volume & Liquidity 0.96× 3-mo avg
Today 277,874 3-mo avg 289.1K
1W
341.9K
1M
239.0K
3M
289.1K
6M
231.5K
YTD
239.7K
1Y
238.6K

GNLX most recently traded 277,874 shares against a 3-month average daily volume of 289.1K.

More News

Read More
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
September 04, 2026
Via Benzinga
Stay updated with the stocks that are on the move in today's after-hours session. ↗
September 04, 2026
Via Chartmill
News headline image
Genelux Corporation Reports Second Quarter Financial Results and Provides Business Updates
August 13, 2026
From Genelux Corporation
Via GlobeNewswire
News headline image
Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherapy Sensitization with Olvi‑Vec in Ovarian Cancer
June 30, 2026
From Genelux Corporation
Via GlobeNewswire
News headline image
Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates
May 07, 2026
From Genelux Corporation
Via GlobeNewswire
News headline image
Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
March 19, 2026
From Genelux Corporation
Via GlobeNewswire
News headline image
Genelux Corporation to Participate in Upcoming Conferences
February 18, 2026
From Genelux Corporation
Via GlobeNewswire
News headline image
Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners
January 12, 2026
From Genelux Corporation
Via GlobeNewswire
These stocks are gapping in today's session ↗
January 08, 2026
Via Chartmill
News headline image
Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock
January 08, 2026
From Genelux Corporation
Via GlobeNewswire
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
January 08, 2026
Via Chartmill
News headline image
The Great Thaw: Biotech Fundraising Surges as Monte Rosa and Genelux Tap Reopening Markets
January 07, 2026
Via MarketMinute
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
Genelux Corporation Announces Proposed Public Offering of Common Stock
January 07, 2026
From Genelux Corporation
Via GlobeNewswire
News headline image
Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials
January 05, 2026
From Genelux Corporation
Via GlobeNewswire
News headline image
Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer
January 02, 2026
From Genelux Corporation
Via GlobeNewswire
News headline image
Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference
November 26, 2025
From Genelux Corporation
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
November 06, 2025
Via Benzinga
News headline image
Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates
November 05, 2025
From Genelux Corporation
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
October 23, 2025
Via Benzinga
News headline image
Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference
September 02, 2025
From Genelux Corporation
Via GlobeNewswire
News headline image
Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates
August 07, 2025
From Genelux Corporation
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
July 21, 2025
Via Benzinga
News headline image
Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development
July 07, 2025
From Genelux Corporation
Via GlobeNewswire

Frequently Asked Questions

Is Genelux Corporation - Common Stock publicly traded?
Yes, Genelux Corporation - Common Stock is publicly traded.
What exchange does Genelux Corporation - Common Stock trade on?
Genelux Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Genelux Corporation - Common Stock?
The ticker symbol for Genelux Corporation - Common Stock is GNLX on the Nasdaq Stock Market
What is the current price of Genelux Corporation - Common Stock?
The current price of Genelux Corporation - Common Stock is 2.420
When was Genelux Corporation - Common Stock last traded?
The last trade of Genelux Corporation - Common Stock was at 10/16/26 04:00 PM ET
What is the market capitalization of Genelux Corporation - Common Stock?
The market capitalization of Genelux Corporation - Common Stock is 92.09M
How many shares of Genelux Corporation - Common Stock are outstanding?
Genelux Corporation - Common Stock has 92M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap